DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

546.62% 6,746.19% (323.64%) (287.31%)
Piotroski F-Score
5 6 6 6
ROA
4.40% 4.30% 4.51% 4.81%
ROIC
13.96% 13.71% 13.75% 13.90%
Return on Tangible Assets
19.55% 20.03% 19.78% 20.75%
Average Days of Receivables
81.83 79.16 79.48 81.21
Free Cash Flow per Share
18.49 18.12 22.55 25.10
Free Cash Flow
1,332.57 1,344.81 1,519.92 1,625.97
Capital Expenditures
(560.83) (541.69) (507.40) (567.19)
Other line items
Cash ROIC
12.31% 12.36% 13.84% 14.64%
Accounts Receivable Turnover
4.74 4.95 4.79 4.58
Accounts Payable Turnover
15.84 14.87 14.52 14.47
Inventory Turnover
67.58 62.63 63.98 63.64
Average Days of Payables
26.41 27.49 27.00 27.57
Days of Inventory on Hand
5.60 6.34 5.53 5.84
Tax Rate
(0.20) (0.22) (0.22) (0.21)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.13% 12.27% 12.44% 12.36%
Share Based Compensation of Revenue
0.97% 1.03% 1.00% 0.94%
Operating CF/Net income
2.45 2.53 2.59 2.59
Depreciation/Fixed assets
0.25 0.25 0.26 0.26
Capex/Depreciation
(0.80) (0.76) (0.71) (0.80)
Revenue per Share
184.78 183.80 205.30 216.26
Operating CF per Share
26.27 25.42 30.08 33.85
Capex per Share
(7.78) (7.30) (7.53) (8.76)
Capex to Sales
0.04 0.04 0.04 0.04

Fold the line items

Columns are period end dates